Protalix BioTherapeutics Inc/ US74365A1016 /
31/05/2024 21:59:26 | Chg. -0.03 | Volume | Bid- | Demandez à- | Haut | Bas |
---|---|---|---|---|---|---|
1.12USD | -2.62% | 11,688 Chiffrre d'affaires: 13,117.95 |
-Bid taille: - | -Ask la taille: - | 1.15 | 1.12 |
GlobeNewswire
22:15
Earlyworks and ZenmuTech collaborate for a more secure digital society through secret splitting and ...
GlobeNewswire
22:10
Consolidated Water Announces Partial Adjournment of Annual General Meeting and Information for Recon...
GlobeNewswire
22:07
Triumph Financial Announces Dividend for 7.125% Series C Fixed-Rate Non-Cumulative Perpetual Preferr...
GlobeNewswire
22:05
TEN, Ltd. Announces Date of First Quarter 2024 Results, Conference Call and Webcast
GlobeNewswire
22:05
Delisting of Securities of RiskOn International, Inc.; Graphjet Technology; Agile Therapeutics, Inc....
GlobeNewswire
22:05
Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting P...
GlobeNewswire
22:01
Wayne Savings Bancshares, Inc. and Main Street Financial Services Corp. Complete Merger
GlobeNewswire
22:01
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
21:35
Great Southern Bancorp, Inc. Announces Second Quarter 2024 Preliminary Earnings Release Date and Con...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page